Literature DB >> 19885245

Bariatric surgery and type 2 diabetes mellitus: surgically induced remission.

Talar Tejirian1, Candice Jensen, Erik Dutson.   

Abstract

The relationship between obesity and type 2 diabetes mellitus (T2DM) is well known. Morbidly obese patients with T2DM who undergo bariatric surgery have improvement or remission of their diabetes. Different types of bariatric operations offer varying degrees of T2DM remission. These operations are classified as restrictive, malabsorptive, or a combination of both. The gold-standard operation, known as the Roux-en-Y gastric bypass, is a combination operation.Most often, improvement of the diabetes is seen within days of the operation. Various theories to explain this rapid change include calorie restriction and hormonal changes from exclusion of the upper gastrointestinal tract. Weight loss accounts for the sustained improvements in glucose control. The patients who benefit the most are those who are early in their disease course.Having a single treatment for both obesity and T2DM is ideal. As bariatric surgery has become a safe operation when performed by experienced surgeons, it should be considered a treatment for these diseases. The impact it can have on the lives of individual patients and society as a whole is tremendous.

Entities:  

Keywords:  bariatric; gastric bypass; remission; type 2 diabetes

Year:  2008        PMID: 19885245      PMCID: PMC2769774          DOI: 10.1177/193229680800200420

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  49 in total

Review 1.  Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?

Authors:  David E Cummings; Michael H Shannon
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

2.  Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.

Authors:  Susumu Suzuki; Eduardo J B Ramos; Carolina G Goncalves; Chung Chen; Michael M Meguid
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

Review 3.  Quality assurance in bariatric surgery.

Authors:  Stewart E Rendon; Walter J Pories
Journal:  Surg Clin North Am       Date:  2005-08       Impact factor: 2.741

4.  Gastric bypass operation for obesity.

Authors:  M A Fobi; H Lee; R Holness; D Cabinda
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

5.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

6.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

7.  Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.

Authors:  Nicholas A Tritos; Edward Mun; Anne Bertkau; Rebecca Grayson; Eleftheria Maratos-Flier; Allison Goldfine
Journal:  Obes Res       Date:  2003-08

8.  Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

Authors:  Ronald H Clements; Quintin H Gonzalez; Calvin I Long; Gary Wittert; Henry L Laws
Journal:  Am Surg       Date:  2004-01       Impact factor: 0.688

9.  How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.

Authors:  Alberto Patriti; Maria Cristina Aisa; Claudia Annetti; Angelo Sidoni; Francesco Galli; Ivana Ferri; Nino Gullà; Annibale Donini
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

10.  Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study.

Authors:  S D Long; K O'Brien; K G MacDonald; N Leggett-Frazier; M S Swanson; W J Pories; J F Caro
Journal:  Diabetes Care       Date:  1994-05       Impact factor: 19.112

View more
  4 in total

1.  Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m(2)) patients.

Authors:  Myung Jin Kim; Kyung Yul Hur
Journal:  Obes Surg       Date:  2014-07       Impact factor: 4.129

2.  Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients.

Authors:  Osama Taha; Mahmoud Abdelaal; Mohamed Abozeid; Awny Askalany; Mohamed Alaa
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

3.  Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

Authors:  Hong Chan Lee; Mee Kyoung Kim; Hyuk Sang Kwon; Eungkook Kim; Ki-Ho Song
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

4.  Laparoscopic sleeve gastrectomy for weight loss and treatment of type 2 diabetes mellitus.

Authors:  Khalid R Murshid; Ghassan H Alsisi; Fayruz A Almansouri; Maram M Zahid; Alaa A Boghdadi; Enas H Mahmoud
Journal:  J Taibah Univ Med Sci       Date:  2021-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.